CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.
By T. Dolecek, J. M. Propp, N. Stroup, C. Kruchko. Neuro-Oncology, 2012
1,565 citations recorded by the source corpus.
Subfields: Genetics, Neurology
View Paper: https://www.semanticscholar.org/paper/602dd1a0d5d19dfff9dd1f916cf63f4478e0b42f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Jill S. Barnholtz-Sloan
- Christopher Sander
- Peter W. Laird
- Richard A. Gibbs
- David Haussler
- Marco A. Marra
- Gad Getz
- Richard K. Wilson
In Neurology
Citations in the corpus
- The Somatic Genomic Landscape of Glioblastoma (2013, background): “Although reported median survival for patients with GBM ranges from 12–18 months, a subset of individuals will survive for more than 3 years (Dolecek et al., 2012; Dunn et al., 2012).”
- Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T cells in Patients with Recurrent Glioblastoma (2015, background): “Despite aggressive standard-of-care therapies, including surgery, radiation, and chemotherapy, glioblastoma (GBM) remains one of the most universally lethal human cancers, with a 5-year survival rate of less than 10% (1).”